Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients

Walking limitation assessment in multiple sclerosis patients (MSPs) is a demanding task, especially in the clinical setting. The aim of this study is to correlate the visual analogue scale (VAS), a simple method for measuring subjective experience, with measures of walking ability used in clinical r...

Full description

Saved in:
Bibliographic Details
Published in:Acta neurologica Belgica Vol. 113; no. 4; pp. 397 - 402
Main Authors: Filipović Grčić, Petar, Matijaca, Meri, Bilić, Ivica, Džamonja, Gordan, Lušić, Ivo, Čaljkušić, Krešimir, Čapkun, Vesna
Format: Journal Article
Language:English
Published: Milan Springer Milan 01-12-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Walking limitation assessment in multiple sclerosis patients (MSPs) is a demanding task, especially in the clinical setting. The aim of this study is to correlate the visual analogue scale (VAS), a simple method for measuring subjective experience, with measures of walking ability used in clinical research of MS. The study included 82 ambulatory MSPs who have resided in the local community. The applied measures of walking ability were the following: the single-item and patient-rated Walking Ability Visual Analogue Scale (WA-VAS), the Expanded Disability Status Scale (EDSS), the 25-foot walk test (25FWT), the Six Spot Step Test (SSST), the 2 min timed walk (2 min TW), the Multiple Sclerosis Walking Scale-12 (MSWS-12), and step activity monitor accelerometer (SAM) during 7 day period. The SAM analysis included the average daily step count, the average steps/min of the highest 1 min of a day, and the average steps/min of the highest continuous 60 min of a day. The WA-VAS scores significantly and strongly correlated with EDSS ( ρ  = 0.679, P  < 0.001), 25FWT ( ρ  = 0.606, P  < 0.001), SSST ( ρ  = 0.729, P  < 0.001), 2 min TW ( ρ  = −0.643, P  < 0.001), MSWS-12 ( ρ  = 0.746, P  < 0.001), average daily step count ( ρ  = –0.507, P  < 0.001), average steps/min of the highest 1 min of a day ( ρ  = –0.544, P  < 0.001), and average steps/min of the highest continuous 60 min of a day ( ρ  = −0.473, P  < 0.001). Correlations between WA-VAS and measures of walking ability used in clinical research of MS were satisfactory. The results obtained in this research indicate that the WA-VAS could be an instrument for simple measurement of walking limitations in MSPs in the clinical setting.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-9009
2240-2993
DOI:10.1007/s13760-013-0187-5